Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes to Distribute Invitrogen Clones in Europe

NEW YORK (GenomeWeb News) – Invitrogen has signed up ImaGenes as a distributor for its Gateway ORF clones in Europe, ImaGenes said.
 
The Gateway system is used in restriction-free cloning and protein expression. ImaGenes said it plans to distribute the clones through its web-based clone portal, called GenomeCube.
 
The Berlin-based company is a spin-off of RZPD German Resource Center for Genome Research, a former Invitrogen distributor, and through a tri-lateral agreement ImaGenes has taken over the European distribution rights from RZPD. The center shut down in July 2007 and transferred its services operations to ImaGenes and Atlas Biolabs.
 
Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more